NASDAQ:NKTR

Nektar Therapeutics Stock Insider Trading

etoro logo Buy NKTR
*Your capital is at risk
$72.76
+2.17 (+3.07%)
At Close: Aug 04, 2026

Nektar Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -47.16. In total, the insiders bought 1.18M and sold 268.74K NKTR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-47.16
Buy 1.18M shares
Sell 268.74K shares
34% Buy Activity
Moderate Negative Correlation
Sell Signal Medium Confidence
Jun 17, 2026

Analysis Breakdown:

  • Supported by a negative Insider Power Score of -47.16.
  • Partially supported by a negative historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Sep 05, 2025
Sell
Common Stock
S-Sale
Robin Howard W
President & CEO
CEO / President 3 304
Value: $125.1K
Sep 04, 2025
Sell
Common Stock
S-Sale
Zalevsky Jonathan
Chief R&d Officer
Officer 793
Value: $25.7K
Sep 04, 2025
Sell
Common Stock
S-Sale
Zalevsky Jonathan
Chief R&d Officer
Officer 432
Value: $14.5K
Sep 04, 2025
Sell
Common Stock
S-Sale
Zalevsky Jonathan
Chief R&d Officer
Officer 189
Value: $7K
Sep 04, 2025
Sell
Common Stock
S-Sale
Zalevsky Jonathan
Chief R&d Officer
Officer 307
Value: $11.0K
Sep 04, 2025
Sell
Common Stock
S-Sale
Robin Howard W
President & CEO
CEO / President 1 923
Value: $62.2K
Sep 04, 2025
Sell
Common Stock
S-Sale
Robin Howard W
President & CEO
CEO / President 1 496
Value: $50.2K
Sep 04, 2025
Sell
Common Stock
S-Sale
Robin Howard W
President & CEO
CEO / President 613
Value: $21.1K
Sep 04, 2025
Sell
Common Stock
S-Sale
Robin Howard W
President & CEO
CEO / President 1 134
Value: $40.6K
Sep 04, 2025
Sell
Common Stock
S-Sale
Robin Howard W
President & CEO
CEO / President 1 134
Value: $40.6K
Sep 04, 2025
Sell
Common Stock
S-Sale
Robin Howard W
President & CEO
CEO / President 613
Value: $21.1K
Sep 04, 2025
Sell
Common Stock
S-Sale
Robin Howard W
President & CEO
CEO / President 1 496
Value: $50.2K
Sep 04, 2025
Sell
Common Stock
S-Sale
Robin Howard W
President & CEO
CEO / President 1 923
Value: $62.2K
Sep 04, 2025
Sell
Common Stock
S-Sale
Zalevsky Jonathan
Chief R&d Officer
Officer 307
Value: $11.0K
Sep 04, 2025
Sell
Common Stock
S-Sale
Zalevsky Jonathan
Chief R&d Officer
Officer 189
Value: $7K
Sep 04, 2025
Sell
Common Stock
S-Sale
Zalevsky Jonathan
Chief R&d Officer
Officer 432
Value: $14.5K
Sep 04, 2025
Sell
Common Stock
S-Sale
Zalevsky Jonathan
Chief R&d Officer
Officer 793
Value: $25.7K
Sep 02, 2025
Sell
Common Stock
S-Sale
Zalevsky Jonathan
Chief R&d Officer
Officer 485
Value: $14.6K
Sep 02, 2025
Sell
Common Stock
S-Sale
Robin Howard W
President & CEO
CEO / President 1 500
Value: $45.2K
Sep 02, 2025
Sell
Common Stock
S-Sale
Robin Howard W
President & CEO
CEO / President 1 500
Value: $45.2K
Sep 02, 2025
Sell
Common Stock
S-Sale
Zalevsky Jonathan
Chief R&d Officer
Officer 485
Value: $14.6K
Aug 19, 2025
Sell
Common Stock
S-Sale
Zalevsky Jonathan
Chief R&d Officer
Officer 725
Value: $19.3K
Aug 19, 2025
Buy
Stock Option
A-Award
Zalevsky Jonathan
Chief R&d Officer
Officer 16 666
Value: $8K
Aug 19, 2025
Buy
Stock Option
A-Award
Wilson Mark Andrew
Chief Legal Officer
Officer 21 666
Value: $10.8K
Aug 19, 2025
Sell
Common Stock
S-Sale
Wilson Mark Andrew
Chief Legal Officer
Officer 676
Value: $18.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT NEKTAR THERAPEUTICS
Nektar Therapeutics
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, squamous cell carcinoma of the head and neck, and a...
GOLDEN STAR
Ticker Change Signal Date
FCX
$62.63
7.46% Jul 31
MC
$67.08
2.40% Jul 31
ARW
$212.85
6.96% Jul 30
BIIB
$202.19
3.10% Jul 24
F
FERG
$230.67
10.77% Jul 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE